Scott Thomas Smith insider trades

Open-market stock purchases and sales by Scott Thomas Smith, EVP & Chief Financial Officer at Ascendis Pharma A/S, from SEC Form 4 filings since May 29, 2026.

Recent trades

DateStockTradeValue
Jun 2, 2026ASND Ascendis Pharma A/SBought$21.9K
May 29, 2026ASND Ascendis Pharma A/SBought$55.8K

Companies traded

  • ASND Ascendis Pharma A/S: 2 buys, last Jun 2, 2026

Get free alerts when Scott Thomas Smith files a new trade →